129 related articles for article (PubMed ID: 37981084)
1. Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
Feng B; Zheng Y; Zhang J; Tang M; Na F
Radiother Oncol; 2024 Jan; 190():110014. PubMed ID: 37981084
[TBL] [Abstract][Full Text] [Related]
2. First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer.
Li L; Yang D; Min Y; Liao A; Zhao J; Jiang L; Dong X; Deng W; Yu H; Yu R; Zhao J; Shi A
BMC Cancer; 2023 Apr; 23(1):318. PubMed ID: 37024843
[TBL] [Abstract][Full Text] [Related]
3. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a Bayesian network meta-analysis.
Zhang T; Li W; Diwu D; Chen L; Chen X; Wang H
Front Immunol; 2023; 14():1197044. PubMed ID: 37435087
[TBL] [Abstract][Full Text] [Related]
6. Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.
Hoffmann E; De-Colle C; Potkrajcic V; Baumann D; Spengler W; Gani C; Utz D
Strahlenther Onkol; 2023 Jul; 199(7):668-675. PubMed ID: 37039832
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.
Li H; Zhao Y; Ma T; Shao H; Wang T; Jin S; Liu Z
Front Immunol; 2023; 14():1132482. PubMed ID: 37701437
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
Zhang S; Li S; Cheng Y
Thorac Cancer; 2020 Dec; 11(12):3536-3546. PubMed ID: 33058504
[TBL] [Abstract][Full Text] [Related]
9. Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series.
Diamond BH; Verma N; Shukla UC; Park HS; Koffer PP
Adv Radiat Oncol; 2022; 7(2):100883. PubMed ID: 35387416
[TBL] [Abstract][Full Text] [Related]
10. Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies.
Luo H; Song G; Wang D; Li M; Dai N
Front Immunol; 2022; 13():1059557. PubMed ID: 36544769
[TBL] [Abstract][Full Text] [Related]
11. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
[TBL] [Abstract][Full Text] [Related]
13. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
[TBL] [Abstract][Full Text] [Related]
14. Differential Effect of Consolidative Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer Based on Sex.
Jairam V; Soulos PR; K C M; Gross CP; Slotman BJ; Chiang AC; Park HS
Adv Radiat Oncol; 2024 Apr; 9(4):101413. PubMed ID: 38778819
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models.
Zheng J; Deng Y; Huang B; Chen X
Front Med (Lausanne); 2023; 10():1198950. PubMed ID: 37583422
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis.
Cai Z; Gu X; Xie J; Cheng D; Chen J; Cheng J; Ye J; Lv T
Transl Lung Cancer Res; 2023 Oct; 12(10):1987-2000. PubMed ID: 38025813
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of PD-(L)1 inhibitor plus chemotherapy versus chemotherapy as first-line treatment in extensive-stage small-cell lung cancer.
Lu J; Lei X; Zhang P; Du L; Zhang Z; Qu B
Cancer Med; 2023 Sep; 12(17):17924-17933. PubMed ID: 37563966
[TBL] [Abstract][Full Text] [Related]
18. Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis.
Sathiyapalan A; Febbraro M; Pond GR; Ellis PM
Curr Oncol; 2022 Nov; 29(12):9046-9065. PubMed ID: 36547123
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study.
Qin B; Xin L; Liang C; Li L; Song Q; Long Y; Zhang X; Wang D; Shi W; Zhang J; Hu Y; Yang B; Xiong Q
BMC Cancer; 2024 Jan; 24(1):100. PubMed ID: 38233798
[TBL] [Abstract][Full Text] [Related]
20. Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.
Wu JJ; Huang JW; Hsu KH; Huang YH; Chen KC; Tseng JS; Yang TY; Chang GC
Anticancer Drugs; 2022 Nov; 33(10):e842-e849. PubMed ID: 36206101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
